Login / Signup

Practical approaches and costs for provisioning safe transfusions during anti-CD38 therapy.

Waseem Q AnaniMarisela G MarchanKathleen M BensingMichael SchanenCindy PieferJerome L GottschallGregory Andrew Denomme
Published in: Transfusion (2017)
Genotyping provided a more accurate antigen status than phenotyping patient RBCs. Patients requiring long-term transfusion support benefit from antigen matching when matching less than four antigens. Ultimately, the decision to genotype or use thiol-treated RRC antibody investigations will vary for each hospital blood bank.
Keyphrases